Two Radio Advertisers Among FTC Targets For Allegedly Unsupported Ad Claims

FTC Targets Two

MEDIFAST's JASON PHARMACEUTICALS, which advertises diet products on radio and in other media, has agreed to pay $3.7 million to settle FEDERAL TRADE COMMISSION charges that its advertising claims were unsupported.  The settlement also blocks the company, which makes the MEDIFAST restricted-calorie plan, from making claims that its meal replacement program produces a particular amount of weight loss.

In addition, the FTC has filed deceptive advertising charges against two manufacturers of bed bug prevention substances, one of which advertises its product on radio.  

CEDARCIDE INDUSTRIES, maker of "BEST YET!," and RMB GROUP LLC, which distributes "REST EASY," were sued in federal court, and after RMB agreed to settle the case by paying $264,976 and stopping claims that the product kills or blocks bed bugs, CEDARCIDE has not yet settled the case against it.  

The FTC quoted a CEDARCIDE radio ad as claiming, "In light of the recent bed bug media frenzy that has all of us nervous, you need to know that bed bug prevention and eradication relief are available.  So let’s not all freak out.  All you need is BEST YET from CEDARCIDE.COM ... BEST YET was developed at the request of the USDA for our military, as a solution for killing sand fleas. But guess what, it’s equally deadly to bed bugs, larvae and eggs.”

« see more Net News